Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Publication year range
1.
Life Sci ; 82(11-12): 638-43, 2008 Mar 12.
Article in English | MEDLINE | ID: mdl-18261747

ABSTRACT

In the course of a project aimed to clarify the molecular mechanisms by which phorbol 12-myristate 13-acetate (PMA)-activated forms of protein kinase C (PKC) promote growth arrest in an MCF-7 cell line, we found that the PKCdelta inhibitor Rottlerin was able by itself to block cell proliferation. In the current study, we investigated further the antiproliferative response to Rottlerin. Western blotting analysis of cytoplasmic/nuclear extracts showed that the drug did not prevent either extracellular signal-regulated kinase (ERK) activation by PMA or Akt phosphorylation, but did interfere with the NFkappaB activation process (both basal and PMA-stimulated), by lowering the levels of phospho-IkappaBalpha and preventing p65 nuclear migration. The growth arrest evoked by Rottlerin was not mediated by cell-cycle inhibitors p21 and p27 but was accompanied by a dramatic fall in the cyclin-D1 protein, the levels of which were not altered by the pan-PKC inhibitor GF 109203X, thus excluding a PKC-mediated mechanism in the Rottlerin effect. The parallel drop in cyclin-D1 mRNA suggested a down-regulation of the gene caused by the inhibition of nuclear factor-kappa B (NFkappaB), which occurs via a PKC-, Akt-, ERK- and mitochondrial uncoupling-independent mechanism. We provide preliminary evidence that the interference on the NFkappaB activation process likely occurs at the level of calcium/calmodulin-dependent protein kinase II (CaMKII), a known Rottlerin target. Indeed the drug prevented calcium-induced CaMKII autophosphorylation which, in turn, led to decreased NFkappaB activation.


Subject(s)
Acetophenones/metabolism , Benzopyrans/metabolism , Cyclin D1/metabolism , Enzyme Inhibitors/metabolism , NF-kappa B/metabolism , Signal Transduction/physiology , Acetophenones/pharmacology , Benzopyrans/pharmacology , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Cell Line, Tumor/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Cyclin D1/genetics , Enzyme Inhibitors/pharmacology , Extracellular Signal-Regulated MAP Kinases/metabolism , Female , Humans , Indoles/metabolism , Indoles/pharmacology , Maleimides/metabolism , Maleimides/pharmacology , Proto-Oncogene Proteins c-akt/metabolism
2.
Cancer Invest ; 26(1): 13-21, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18181040

ABSTRACT

Although PKCs are assumed to be the main targets of phorbol esters (PMA), additional PMA effectors, such as chimaerins (a family of RacGTPase activating proteins) and RasGRP (exchange factor for Ras/Rap1), can counteract or strengthen the PKC pathways. In this study, we evaluated the proliferative behavior of PMA-treated MCF-7 breast cancer cell and found that: PMA induced growth arrest and inhibited cell death; PMA activated ERKs, which, in turn, induced p21; and inhibitors of ERK (PD98059) and PKC (GF109203X) prevented p21 induction and abolished the PMA survival effect. We conclude that PMA inhibits MCF-7 cell growth and simultaneously stimulates cell survival; both responses are linked to ERK-dependent and p53-independent p21 induction.


Subject(s)
Breast Neoplasms/metabolism , Cell Survival/drug effects , Enzyme Activation/drug effects , Signal Transduction/drug effects , Tetradecanoylphorbol Acetate/pharmacology , Blotting, Western , Cell Line, Tumor , Cell Proliferation/drug effects , Enzyme Inhibitors/pharmacology , Extracellular Signal-Regulated MAP Kinases/drug effects , Extracellular Signal-Regulated MAP Kinases/metabolism , Female , Flavonoids/pharmacology , Fluorescent Antibody Technique , Gene Expression/drug effects , Humans , Immunohistochemistry , Phorbol Esters/pharmacology , Proliferating Cell Nuclear Antigen/drug effects , Proliferating Cell Nuclear Antigen/metabolism , Tumor Suppressor Protein p53/drug effects , Tumor Suppressor Protein p53/metabolism , p21-Activated Kinases/drug effects , p21-Activated Kinases/metabolism
3.
Food Addit Contam ; 24(9): 923-34, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17691005

ABSTRACT

Investigations were undertaken to identify causes for the occurrence of high levels of the zootechnical feed additive nicarbazin in broiler liver at slaughter. The first investigation on 32 commercial broiler flocks involved sampling and analysis for nicarbazin (as dinitrocarbanilide, DNC) in liver from birds during a 3-10-day period after withdrawal of nicarbazin from their feed and before commercial slaughter. DNC residues in liver samples of broilers scheduled as being withdrawn from nicarbazin for > or =6 days ranged from 20 to >1600 microg kg(-1) (the specified withdrawal period for nicarbazin is 5 days and the Joint Expert Committee on Food Additives (JECFA) maximum residue limit (MRL) is 200 microg kg(-1) liver). Further on-farm investigations on 12 of these flocks, selected on the basis of the feeding system in use and the levels of DNC residues determined in liver, identified issues in feed management contributing to elevated residues in broiler liver. A significant correlation (0.81, p < 0.01, n = 10) between DNC residues in liver samples and in feed samples from the feeding pans was observed. The second investigation on 12 commercial broiler flocks involved sampling and analysis for DNC in liver samples and feed samples from feeding pans and from the feed mill at the three thinnings of birds for commercial slaughter. In the case of one flock, a clear relationship between nicarbazin in feed from the feed mill (10.5 mg kg(-1) DNC), in feed from the feeding pans (6.6 mg kg(-1) DNC) and in liver (583 microg kg(-1) DNC) at first thinning (9 days scheduled withdrawal from nicarbazin) was observed. Such a clear relationship was not observed in other cases, particularly at second and third thinnings, pointing to re-exposure of birds to nicarbazin late in the flock production cycle, probably from the litter. Guidelines outlining best farm practice to eliminate nicarbazin residues in poultry have been published in booklet and poster format for broiler producers and deal with feed system cleaning, feed bin management, feed deliveries, feed usage and records.


Subject(s)
Chickens/metabolism , Coccidiostats/analysis , Food Additives/analysis , Nicarbazin/analysis , Animal Feed/analysis , Animal Husbandry/methods , Animals , Carbanilides/analysis , Liver/metabolism
4.
J Mol Endocrinol ; 33(2): 335-41, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15525593

ABSTRACT

We have recently demonstrated that human alpha-atrial natriuretic peptide (alpha-hANP), an amyloidogenic peptide responsible for isolated atrial amyloidosis, binds to a dimeric form of apo A-I belonging to small high-density lipoproteins (HDL). This binding phenomenon is considered a protective mechanism since it inhibits or strongly reduces the ANP aggregation process. The observation that plasma exhibits at least four times greater amyloid inhibitory activity than HDL prompted us to determine whether small HDL are the only ANP plasma-binding factors. After incubation of whole plasma with labelled ANP, the macromolecular complexes were subjected to two-dimensional gel electrophoresis followed by autoradiography. The results presented here provide novel evidence of additional binding proteins, in addition to apo A-I dimer, able to bind ANP in vitro and to prevent its aggregation. The mass spectrometry analysis of the radioactive spots identified them as albumin, alpha-1 antitrypsin, orosomucoid and apo A-IV-TTR complex. The putative impact of these findings in the amyloidogenic/antiamyloidogenic peptides network is discussed.


Subject(s)
Atrial Natriuretic Factor/metabolism , Blood Proteins/metabolism , Amyloidosis/blood , Apolipoprotein A-I/analysis , Apolipoprotein A-I/metabolism , Apolipoproteins A/analysis , Apolipoproteins A/metabolism , Blood Proteins/analysis , Dimerization , Electrophoresis, Gel, Two-Dimensional/methods , Electrophoresis, Polyacrylamide Gel/methods , Humans , Iodine Radioisotopes/metabolism , Lipoproteins, HDL/blood , Lipoproteins, HDL/metabolism , Orosomucoid/analysis , Orosomucoid/metabolism , Prealbumin/analysis , Prealbumin/metabolism , Serum/metabolism , Serum Albumin/analysis , Serum Albumin/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , alpha 1-Antitrypsin/analysis , alpha 1-Antitrypsin/metabolism
5.
Monaldi Arch Chest Dis ; 60(1): 85-91, 2003 Mar.
Article in Italian | MEDLINE | ID: mdl-12827838

ABSTRACT

Cigarette smoking and nicotine dependence represent a complex disease. In the treatment program design the combination of non pharmacological and pharmacological therapy, the concurrence of physicians and other health professionals has been demonstrated the most successful therapeutic approach. This article reviews the main evidence based non pharmacological interventions. Social support request, self-monitoring and smoking behaviour modification are cornerstones of the preparation to quit. Post cessation counselling is mainly focused on problem solving activities. The complementary use of exercise and relaxation training is also evaluated.


Subject(s)
Counseling/methods , Smoking Cessation/methods , Tobacco Use Disorder/psychology , Tobacco Use Disorder/therapy , Complementary Therapies , Humans
6.
Monaldi Arch Chest Dis ; 58(2): 174-82, 2002 Sep.
Article in Italian | MEDLINE | ID: mdl-12418435

ABSTRACT

In the last few years the population referred to cardiac rehabilitation centers has changed profoundly: the number of survivors of acute cardiac events has increased and heart surgery is being proposed to ever greater numbers of elderly patients with frequent and greater comorbidities, which make the management of physical training programs more complex. Consequently, just as rehabilitation cardiologists have had to expand their field of analyses and professional skills and nurses have had to integrate their care protocols, physiotherapists too have had to adapt the management of motor rehabilitation programs to the various needs and problems of each patient in the different phases of recovery. The aim of this paper is to present and discuss the procedures followed in our center concerning both the mode and contents of a standard course of motor rehabilitation for patients without complications and those for patients with complications. The paper analyzes the various assessments, the training program, the instruments of control and verification of the results, and discusses the instruments of intervention in patients affected by complications such as respiratory disturbances, musculoskeletal impairment, complications arising from injury, neurological deficit and severe deconditioning. Finally, the role of the physiotherapist in the active, propositive management of a recovery program is discussed.


Subject(s)
Exercise Therapy , Heart Diseases/rehabilitation , Humans
7.
Int. j. lepr ; 25(2): 119-121, Apr.-Jun. 1957. tab
Article in English | Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1227756

ABSTRACT

Fifty healthy, lepromin-negative individuals living with leprous persons were vaccinated with Tuberculosis Vaccine, Irradiated. In 47 of them the lepromin reaction became positive after one or two courses of the vaccine. We believe that Tuberculosis Vaccine, Irradiated, may prove to be of value because it changes Mitsuda-negative individuals to positive reactors.


Subject(s)
Leprosy , Leprosy/classification , Leprosy/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...